Premium
Parrino perspective from 2019 AATOD conference: Positives and negatives
Author(s) -
Knopf Alison
Publication year - 2019
Publication title -
alcoholism and drug abuse weekly
Language(s) - English
Resource type - Journals
eISSN - 1556-7591
pISSN - 1042-1394
DOI - 10.1002/adaw.32521
Subject(s) - buprenorphine , methadone , negative , opioid addiction , magic (telescope) , medicine , art , opioid , psychiatry , visual arts , physics , quantum mechanics , receptor
Opioids have put the American Association for the Treatment of Opioid Dependence (AATOD) front and center when it comes to medication‐assisted treatment with methadone in particular, but also with buprenorphine and naltrexone. Mark W. Parrino, AATOD president, told the 2,000 or so attendees at the AATOD conference in Orlando last week about the positives and negatives that have occurred in the past year. Amid all the festivity and “magic” of Disney and the deluxe Coronado Springs Resort, there are very serious issues facing the field in terms of growth and patient care.